Maryland - August 20, 2004 - Chindex
International, Inc. (NASDAQ:CHDX), an independent American provider
of Western healthcare products and medical services in the People's
Republic, today announced the appointment of Douglas B.Grob and Holli
Harris to the Company's Board of Directors.
is currently an Assistant Professor, Department of Government and
Politics, University of Maryland, College Park. Mr. Grob has also
served as a Visiting Scholar at the School of Law of Beijing University
and as a Research Fellow at the Asia/Pacific Research Center of Stanford
University. Prior to his academic career, he served as Director of
Business Development for Chindex International, Inc. and as an Analyst
and Assistant Treasurer for Chase Manhattan Bank. He has an A.B. degree
from the University of Pennsylvania, two masters degrees, and a Ph.D.
in Political Science from Stanford University.
currently helps lead efforts to grow Seattle-based Corbis Corporation's
international revenues. She has served as a U.S. State Department
official at the U.S. Embassy in Moscow, and, after that service, she
helped to structure oil and gas transactions for several companies
in Russia. She has since conducted business development in the biotech
and industrial design industries, and has also worked with Fortune
500 companies in developing cross-industry product ideas incorporating
emerging technologies. Ms. Harris holds a dual degree in Russian and
International Relations from the University of California - Davis
and an MBA in Finance from the University of Michigan.
"We are very
pleased that Doug and Holli has joined our Board," said Roberta Lipson,
Chindex President, Chairperson and CEO. "Doug & Holli bring to
Chindex an added dimension of professionalism and outstanding qualifications,
as well as bountiful experience which will add tremendously to our
is an American company operating in several healthcare sectors of
the Chinese marketplace, including Hong Kong. It provides representative
and distribution services to a number of major multinational companies
including Siemens AG (ultrasound systems), and Guidant (interventional
cardiology products including stents, balloon catheters and guide
wires). Its distribution channels to the retail pharmacy industry
in China have been developed through a relationship with a major multinational
cosmetics manufacturer. It also provides healthcare services through
the operations of its private hospital corporation in China. With
twenty-three years of experience, over 700 employees, and operations
in the United States, China and Hong Kong, the Company's strategy
is to expand its cross-cultural reach by providing leading edge technologies,
quality products and services to Greater China's professional communities.
Further company information may be found at the Company's websites,
www.chindex.com and www.unitedfamilyhospitals.com.